Clinical Trial Detail

NCT ID NCT01767792
Title Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies

Bevacizumab

Age Groups: adult child

No variant requirements are available.